ArticleJournal of thoracic disease2026

Real world comparative outcomes of adjuvant carboplatin versus cisplatin-based chemotherapy in stage IB-IIIA non-small cell lung cancer: a propensity-weighted analysis.

Molly Tokaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.